Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
45.28
+0.49 (1.09%)
Feb 6, 2026, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.64 billion as of February 9, 2026. Its market cap has increased by 27.68% in one year.
Market Cap
4.64B
Enterprise Value
3.60B
1-Year Change
27.68%
Ranking
Category
Stock Price
$45.28
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.64B, an increase of 723.11%. That is a compound annual growth rate of 32.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 4.64B | 5.08% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 5.28B |
| Structure Therapeutics | 5.18B |
| Celcuity | 4.94B |
| Scholar Rock Holding | 4.86B |
| CRISPR Therapeutics AG | 4.64B |
| Amicus Therapeutics | 4.49B |
| Corcept Therapeutics | 4.29B |
| TG Therapeutics | 4.22B |